针对性治疗在先进的胆管癌中
Michael H Storandt1, Peter C Kurniali2,3, Amit Mahipal4
1Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Life (Basel, Switzerland)
|October 28, 2023
概括
针对性疗法正在出现,用于胆管癌 (CCA) 管理. 本综述涵盖了关键的分子标,如FGFR2融合和BRAF突变,以及它们对先进的CCA的相应新治疗方法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 胆管癌 (CCA) 的管理依赖于早期阶段的手术.
- 晚期或转移性CCA目前具有息性全身疗法作为唯一的选择.
- 新兴的向疗法正在改变CCA治疗模式.
研究的目的:
- 审查胆管癌中显著的分子标.
- 总结针对这些目标的新疗法的证据.
- 讨论肝内和肝外CCA中目标的不同频率.
主要方法:
- 针对胆管癌的向治疗方法的文献综述.
- 分子标的分析包括mIDH-1,HER2,FGFR2融合,BRAF V600E,dMMR/MSI-H,以及TMB-H.
- 已批准和正在研究的治疗方法的临床证据摘要.
主要成果:
- 在CCA中确定了几种分子标,包括mIDH-1,HER2和FGFR2融合.
- 有新的向疗法可用,其中一些FDA批准的二线治疗.
- 在肝内和肝外CCA亚型之间,目标频率有所不同.
结论:
- 向疗法代表了胆管癌治疗的重大进步.
- 了解特定的分子变化对于选择适当的疗法至关重要.
- 针对性药物的进一步研究和开发对于改善患者的治疗结果至关重要.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
538
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
538
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


